News (116)

Novartis Eyes Sale of Listed Unit in India CI
AI buzzes Davos, but CEOs wrestle with how to make it pay RE
Novartis drops pursuit of Cytokinetics - source RE
Novartis : Financial Results – Q3 2023 PU
Novartis AG : Sandoz takes its first steps on the stock exchange Our Logo
What happens when a $2 million gene therapy is not enough RE
Novartis Seeks M&A CI
Novartis Seeks M&A CI
Novartis : Financial Results – Q3 2022 PU
Novartis to Seek Acquisitions CI
Novartis : Amendment to Annual Report by Foreign Issuer (Form 20-F/A) PU
Novartis Seeks Bolt-On Acquisitions CI
Transcript : Novartis AG Presents at Co-Creating Impact Summit, Dec-02-2021
NBC Universal : CNBC to Host First Ever “Evolve Global Summit” on June 16 PU
Novartis : Annual Review 2020 PU
Transcript : Novartis AG, Q4 2019 Earnings Call, Jan 29, 2020
Cboe Global Markets : Progenics To Sends Letter To Shareholders, Urges Vote For WHITE Proxy Card PU
Progenics to Mail Letter to Shareholders GL
Transcript : Novartis AG, Q4 2018 Earnings Call, Jan 30, 2019
Novartis : rises to second place in 2018 Access to Medicine Index GL
Transcript : Genmab A/S Presents at Goldman Sachs 39th Annual Global Healthcare Conference, Jun-12-2018 04:00 PM
Novartis : readies to auction U.S. generic pills business - sources RE
Novartis : appoints Elizabeth Barrett as Oncology Head GL
Transcript : Novartis AG - Special Call
Moncef Slaoui Joins Medicxi BU
Fiat Chrysler Automobiles : European shares slip on worries over North Korea nuclear test RE
Novartis AG Announces Executive Changes CI
Novartis : announces CEO Joseph Jimenez to retire from in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018. GL
Novartis : NEJM publishes full analysis of Rydapt® (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML) GL
Novartis : presents data demonstrating efficacy of AMG 334 (erenumab) in migraine prevention at the American Headache Society Annual Meeting GL
Novartis : ' new analyses reinforce the potential of Ultibro® Breezhaler® for COPD patients historically treated with steroids GL
Novartis : NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia GL
Novartis : to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications GL
Novartis : New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes PU
Novartis : New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes GL
Novartis : invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders PU
Novartis : invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders GL
Novartis reaches agreement to buy Texas-based Encore Vision RE
Novartis : bolsters ophthalmology pipeline through acquisition of Encore Vision, Inc. GL
Novartis : announces exclusive option, collaboration and license agreement with Conatus to develop new oral treatments for chronic liver diseases GL
Novartis : says buys Ziarco Group to expand skin care portfolio RE
Novartis : bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited GL
Novartis : provides update on pegpleranib Phase III clinical trial program in patients with neovascular age-related macular degeneration (nAMD or wet AMD) GL
Novartis : ' Ultibro® Breezhaler® improved lung function and COPD symptoms after direct switch from previous treatment GL
Novartis : commends publication of major report which recommends broad use of dual bronchodilators to treat COPD GL
123NextSee all

Companies (3)

B-RIGHT REALESTATE LIMITED 20 M $
Logo B-Right Realestate Limited

B-Right RealEstate Limited is an India-based integrated construction and real estate development company. The Company is engaged in the business of real estate development and investment. It is focused primarily on construction and development of resident ...

KBC GLOBAL LIMITED 23 M $
Logo KBC Global Limited

KBC Global Limited is an India-based company that is engaged in the business of real estate development and construction contracts. The Company’s segments include Development of Real Estate Property and Civil Contracting Business. Its real estate develo ...

THE GREAT EASTERN SHIPPING COMPANY LIMITED 1 867 M $
Logo The Great Eastern Shipping Company Limited

The Great Eastern Shipping Company Limited is an India-based private sector shipping company. The Company provides for transportation of crude oil, petroleum products, gas and dry bulk commodities. The Company is engaged in shipping business segment. The ...


Insiders

Vasant Narasimhan
Vasant Narasimhan

Vasant Narasimhan occupies the position of Chief Executive Officer at Novartis AG and Chief Executive Officer of Novartis International AG (a subsidiary of Novartis AG). He is also on the board of Novartis Foundation and Member of Institute of Medicine, Member of National Academy of Medicine of United States and Treasurer & Director at Pharmaceutical Research & Manufacturers of America. In his past career he occupied the position of President of Novartis Vaccines & Diagnostics, Inc., Global Head-Development at Novartis Vaccines & Diagnostics, Inc., Global Head-Development at Novartis Pharmaceuticals and Global Head-Development at Sandoz Pharmaceuticals AG. He received a graduate degree from Harvard Medical School, a graduate degree from Harvard Kennedy School of Government and an undergraduate degree from The University of Chicago.




Picture Narasimhan Narayanan
Narasimhan Narayanan

Narasimhan Narayanan has held various director positions in multiple companies including Pyramid Saimira Theatre Ltd., Dimples Cine Advertising Pvt Ltd., Regent Saimira Entertainment, and Pyramid Saimira Content Distribution Pvt Ltd.



Picture Serangulam Varadarajan Narasimhan
Serangulam Varadarajan Narasimhan

Serangulam Varadarajan Narasimhan served as Non-Executive Chairman at Lanka IOC Plc from 1975 to 2010.
He also worked as Director & Finance Director at Indian Oil Corp.
Ltd.
from 1975 to 2011.
Additionally, he served as Managing Director at Chennai Petroleum Corp.
Ltd.
and as Non-Executive Director at Petronet LNG Ltd.
Narasimhan holds an MBA from the Faculty of Management Studies.


Picture Sundar Narasimhan
Sundar Narasimhan

Sundar Narasimhan is currently the Co-President at Sabre Holdings Corp.
He is also a Senior VP-Product labs & Product Strategy at Sabre Corp.
Previously, he worked as a Product Manager at ITA Software, Inc. from 2011 to 2012.
He also served as the Chief Scientist at Ascent Technology Ltd.
Dr. Narasimhan holds graduate and doctorate degrees from the Massachusetts Institute of Technology, as well as an undergraduate degree from the Indian Institute of Technology Madras.




Picture Narasimhan Raghunathan
Narasimhan Raghunathan

Narasimhan Raghunathan worked as a Secretary, Compliance Officer & DGM-Finance at KSB Ltd.

No results for this search